POSCO Holdings: Solid Performance And Favorable Prospects

POSCO Holdings' 1Q2026 EBIT rose 24.3% YoY and beat the consensus by 20.3%. Click here to read more about PKX stock and why ...
The Manila Times

Facephi Ends 2025 with Solid Performance Across All Key Metrics: Double-Digit Revenue and Tripple-Digit EBITDA Growth. It Returns to Profitability

Facephi Ends 2025 with Solid Performance Across All Key Metrics: Double-Digit Revenue and Tripple-Digit EBITDA Growth. It Returns to Profitability ...

Michelin delivered a solid performance in the first quarter, the decline in revenue reflecting changes in exchange rates. In a highly uncertain environment, the Group is ...

April 29, 2026 COMPAGNIE GÉNÉRALE DES ÉTABLISSEMENTS MICHELIN Financial information for the three months ended March 31, 2026 Michelin delivered a solid performance in the first quarter, the decline ...
The Manila Times

Solid financial performance in the first quarter of 2026 driven by good customer activity, lending growth and strong credit quality Net profit of DKK 5.7 billion

Danske Bank delivered a net profit of DKK 5.7 billion in the first quarter of 2026, a decline of 1% from the level in the first quarter of 2025. Total income increased marginally, driven by increases ...
Seeking Alpha

ETW: Solid Performance As Discount Remains Attractive

Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund remains attractively valued, trading at a deep 10%+ discount to NAV. ETW has shifted its option overwrite strategy from nearly 100% to under ...
The Courier-Journal

Humana posts 'solid' second quarter performance but buyouts, lawsuits, and outsourcing loom

Humana reported a 9.6% revenue increase in Q2 2025, reaching over $32 billion, driven by its CenterWell division and Medicare Advantage membership. Despite revenue growth, Humana offered a voluntary ...

Ermenegildo Zegna Group Reports Solid 2026 Q1 Lifted by DTC, Americas

Executive chairman Gildo Zegna touted "strong momentum" for the group's brands.
Morningstar

Alfasigma Reports Solid Performance in 2025 Supported by Double-Digit Revenue Growth in key strategic brands in Immunology (+17%1), Gastroenterology (+15%), Vascular (+10% ...

Alfasigma S.p.A (“Alfasigma” or the “Company”), a global pharmaceutical company founded over 75 years ago in Italy, where it is headquartered, today announced its financial results for the fiscal year ...